GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Debt-to-EBITDA

Angelalign Technology (HKSE:06699) Debt-to-EBITDA : 1.00 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Angelalign Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$31 Mil. Angelalign Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$40 Mil. Angelalign Technology's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$71 Mil. Angelalign Technology's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Angelalign Technology's Debt-to-EBITDA or its related term are showing as below:

HKSE:06699' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.06   Med: 0.13   Max: 0.94
Current: 0.94

During the past 6 years, the highest Debt-to-EBITDA Ratio of Angelalign Technology was 0.94. The lowest was 0.06. And the median was 0.13.

HKSE:06699's Debt-to-EBITDA is ranked better than
56.49% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs HKSE:06699: 0.94

Angelalign Technology Debt-to-EBITDA Historical Data

The historical data trend for Angelalign Technology's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology Debt-to-EBITDA Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.20 0.06 0.08 0.09 0.42

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.14 0.08 0.59 1.00

Competitive Comparison of Angelalign Technology's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Angelalign Technology's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's Debt-to-EBITDA falls into.



Angelalign Technology Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Angelalign Technology's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(31.349 + 40.05) / 168.871
=0.42

Angelalign Technology's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(31.349 + 40.05) / 71.376
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Angelalign Technology  (HKSE:06699) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Angelalign Technology Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Angelalign Technology (HKSE:06699) Business Description

Traded in Other Exchanges
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Angelalign Technology (HKSE:06699) Headlines

No Headlines